Difference between revisions of "Diabetes medications"

(Text replacement - "Category:Endo" to "Category:Endocrinology")
(Text replacement - "Category:Drugs" to "Category:Pharmacology")
Line 60: Line 60:
  
 
[[Category:Endocrinology]]
 
[[Category:Endocrinology]]
[[Category:Drugs]]
+
[[Category:Pharmacology]]

Revision as of 15:52, 22 March 2016

Background

  • Hypoglycemics
    • Sulfonylureas
    • Benzoic acid derivatives
  • Antihyperglycemics
    • Biguanides
    • Alpha glucosidase inhibitors
    • Thiazolidinediones

Insulin

Biguanides (Metformin)

Suppresses liver glucose production

Dose

Metformin 500mg PO BID is first-line agent for type II diabetics

  • Do not prescribe if Cr > 1.4 (GFR <40), CHF, hepatic insufficiency, ETOH abuse
  • Should be withheld for 48hr after IV contrast

Side Effects

  • Lactic acidosis (due to increased lactate production)
    • Seen almost exclusively in patients with renal failure
  • Nausea, diarrhea, crampy abdominal pain

Toxicity

  • Almost never causes hypoglycemia when taken alone, but can exacerbate hypoglycemia when taken in combination with hypoglycemic agents
  • Toxic dose unknown
  • Management: Supportive care

Sulfonylureas

  • Increases insulin secretion (glipizide, glyburide)
  • Hypoglycemia is the major adverse effect (esp w/ glyburide)

Alpha Glucosidase Inhibitors

  • acarbose, miglitol, voglibose
  • competitively and reversibly inhibit alpha glucosidase brush border hydrolase enzyme- makes postprandial decrease in carbohydrate absorption since complex polysaccharides not broken down into absorbable monosaccharides
  • does not affect lactose absorption
  • if hypoG- sucrose/ table sugar will not work- use glucose- po or iv
  • take these meds with each meal with first bite
  • since limited aborption, stays in gut and side effects mostly GI- bloating, gas, diarrhea
  • contraindications- cirrhosis, IBD, malabsorption synd
  • alpha glucs do not cause hypoG when used as monotx
  • acarbose- can cause transaminitis/ liver inj
  • since min absorption- systemic tox from OD unlikely

Thiazolidinediones

  • rosiglitazone and poiglitazone
  • enhance insulin effect on muscle, fat, liver without increasing panc insulin secretion
  • protein bound and hep metab- not good if liver dz
  • side effects- induce ovulation, increase plasma vol bad if CHF, decrease effectiveness of OCP's

Benzoic Acid Derivatives

  • repaglinide- mono or combo tx c metformin
  • binds to atp dependent potassium channel like sulfonyls but at different site.
  • Unlike sulfonyls, it decreases insulin lvls
  • Dose 30 min before meal to decrease post prandial hyperglycemia

See Also

References

Tintinalli